Blood Immunology & Cellular Therapy
Elsevier · United States
eISSN3050-5976
✓ DOAJ✓ Open Access
15
/ 100
High Risk
Score Breakdown
✓ DOAJ Verified+15
Total15
Aims & Scope✦ Inferred from recent articles
This journal focuses on cellular therapies, particularly CAR T-cell therapies, for hematologic malignancies like multiple myeloma and Hodgkin lymphoma. It also covers research into immune tolerance, graft rejection, and the regulatory aspects of decentralized cell manufacturing.
AI-summarised from recent articles · verify on publisher page →
General Information
Country / RegionUnited States
Primary LanguageEnglish
1st Year Published—
StatusActive
Total Publications—
Submission Info
APC Cost$3,000Above median
Peer ReviewAnonymous peer review
Review Time—
Acceptance Rate—
OA LicenseCC BY, CC BY-NC-ND
OA Rate—
Ethics & Quality
COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Think.Check.Submit Compliance
9/12 · 75%
✅
Do you know the journal / publisher?
✅
Does the journal have a website?
✅
Is the ISSN verified?
✅
Indexed in a trusted database?
✅
Peer review process documented?
❌
Follows ethical publishing standards (COPE)?
✅
APC fees clearly disclosed?
✅
Not on predatory/blacklists?
❌
Long-term digital preservation?
❌
Plagiarism detection in place?
✅
Listed in DOAJ (verified OA)?
✅
Primary language documented?
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Research Topics (OpenAlex)
CAR-T cell therapy researchLymphoma Diagnosis and TreatmentMultiple Myeloma Research and TreatmentsImmune Cell Function and InteractionCutaneous lymphoproliferative disorders researchAcute Lymphoblastic Leukemia researchT-cell and B-cell ImmunologyHematopoietic Stem Cell TransplantationChronic Lymphocytic Leukemia ResearchBiomedical Ethics and Regulation
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref